Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. Virgin olive oil, palm olein and coconut oil diets do not raise cell adhesion molecules and thrombogenicity indices in healthy Malaysian adults High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Consumption of trans fats and estimated effects on coronary heart disease in Iran Epidemiologic studies on dietary fats and coronary heart disease. Randomised trial of coconut oil, olive oil or butter on blood lipids and other cardiovascular risk factors in healthy men and women Reduced bone mineralization in infants fed palm olein-containing formula: a randomized, double-blinded, prospective trial. Behenic acid is a cholesterol-raising saturated fatty acid in humans. Replacement of dietary fat with palm oil: effect on human serum lipids, lipoproteins and apolipoproteins. Replacement of saturated with unsaturated fats had no impact on vascular function but beneficial effects on lipid biomarkers, E-selectin, and blood pressure: results from the randomized, controlled Dietary Intervention and VAScular function (DIVAS) study. Independence of the effects of cholesterol and degree of saturation of the fat in the diet on serum cholesterol in man. Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic acid or high in myristic and lauric acids. Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes. Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study A randomized study of coconut oil versus sunflower oil on cardiovascular risk factors in patients with stable coronary heart disease Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Biomarkers of Dairy Fatty Acids and Risk of Cardiovascular Disease in the Multi‐Ethnic Study of Atherosclerosis Comparison of predictive performance of various fatty acids for the risk of cardiovascular disease events and all-cause deaths in a community-based cohort. Replacement of partially hydrogenated soybean oil by palm oil in margarine without unfavorable effects on serum lipoproteins Palmitic acid in the sn-2 position of dietary triacylglycerols does not affect insulin secretion or glucose homeostasis in healthy men and women Effects of palm olein and olive oil on serum lipids in a Chinese population: a randomized, double-blind, cross-over trial.
BACKGROUND Dietary fat type is known to modulate the plasma lipid profile , but its effects on plasma homocysteine and inflammatory markers are unclear . OBJECTIVE We investigated the effects of high-protein Malaysian diets prepared with palm olein , coconut oil ( CO ) , or virgin olive oil on plasma homocysteine and selected markers of inflammation and cardiovascular disease ( CVD ) in healthy adults . DESIGN A r and omized-crossover intervention with 3 dietary sequences of 5 wk each was conducted in 45 healthy subjects . The 3 test fats , namely palmitic acid (16:0)-rich palm olein ( PO ) , lauric and myristic acid ( 12:0 + 14:0)-rich CO , and oleic acid (18:1)-rich virgin olive oil ( OO ) , were incorporated at two-thirds of 30 % fat calories into high-protein Malaysian diets . RESULTS No significant differences were observed in the effects of the 3 diets on plasma total homocysteine ( tHcy ) and the inflammatory markers TNF-α , IL-1β , IL-6 , and IL-8 , high-sensitivity C-reactive protein , and interferon-γ . Diets prepared with PO and OO had comparable nonhypercholesterolemic effects ; the postpr and ial total cholesterol for both diets and all fasting lipid indexes for the OO diet were significantly lower ( P < 0.05 ) than for the CO diet . Unlike the PO and OO diets , the CO diet was shown to decrease postpr and ial lipoprotein(a ) . CONCLUSION Diets that were rich in saturated fatty acids prepared with either PO or CO , and an OO diet that was high in oleic acid , did not alter postpr and ial or fasting plasma concentrations of tHcy and selected inflammatory markers . This trial was registered at clinical trials.gov as NCT00941837 Background / objectives : Effects of high-protein diets that are rich in saturated fats on cell adhesion molecules , thrombogenicity and other nonlipid markers of atherosclerosis in humans have not been firmly established . We aim to investigate the effects of high-protein Malaysian diets prepared separately with virgin olive oil ( OO ) , palm olein ( PO ) and coconut oil ( CO ) on cell adhesion molecules , lipid inflammatory mediators and thromobogenicity indices in healthy adults . Methods : A r and omized cross-over intervention with three dietary sequences , using virgin OO , PO and CO as test fats , was carried out for 5 weeks on each group consisting of 45 men and women . These test fats were incorporated separately at two-thirds of 30 % fat calories into high-protein Malaysian diets . Results : For fasting and nonfasting blood sample s , no significant differences were observed on the effects of the three test-fat diets on thrombaxane B2 ( TXB2 ) , TXB2/PGF1α ratios and soluble intracellular and vascular cell adhesion molecules . The OO diet induced significantly lower ( P<0.05 ) plasma leukotriene B4 ( LTB4 ) compared with the other two test diets , whereas PGF1α concentrations were significantly higher ( P<0.05 ) at the end of the PO diet compared with the OO diet . Conclusion : Diets rich in saturated fatty acids from either PO or CO and high in monounsaturated oleic acid from virgin OO do not alter the thrombogenicity indices — cellular adhesion molecules , thromboxane B2 ( TXB2 ) and TXB2/prostacyclin ( PGF1α ) ratios . However , the OO diet lowered plasma proinflammatory LTB4 , whereas the PO diet raised the antiaggregatory plasma PGF1α in healthy Malaysian adults . This trial was registered at clinical trials.gov as NCT 00941837 BACKGROUND Low-fat diets increase plasma triacylglycerol and decrease HDL-cholesterol concentrations , thereby potentially adversely affecting cardiovascular disease ( CVD ) risk . High-monounsaturated fatty acid ( MUFA ) , cholesterol-lowering diets do not raise triacylglycerol or lower HDL cholesterol , but little is known about how peanut products , a rich source of MUFAs , affect CVD risk . OBJECTIVE The present study compared the CVD risk profile of an Average American diet ( AAD ) with those of 4 cholesterol-lowering diets : an American Heart Association/National Cholesterol Education Program Step II diet and 3 high-MUFA diets [ olive oil ( OO ) , peanut oil ( PO ) , and peanuts and peanut butter ( PPB ) ] . DESIGN A r and omized , double-blind , 5-period crossover study design ( n = 22 ) was used to examine the effects of the diets on serum lipids and lipoproteins  : AAD [ 34 % fat ; 16 % saturated fatty acids ( SFAs ) , 11 % MUFAs ] , Step II ( 25 % fat ; 7 % SFAs , 12 % MUFAs ) , OO ( 34 % fat ; 7 % SFAs , 21 % MUFAs ) , PO ( 34 % fat ; 7 % SFAs , 17 % MUFAs ) , and PPB ( 36 % fat ; 8 % SFAs , 18 % MUFAs ) . RESULTS The high-MUFA diets lowered total cholesterol by 10 % and LDL cholesterol by 14 % . This response was comparable with that observed for the Step II diet . Triacylglycerol concentrations were 13 % lower in subjects consuming the high-MUFA diets and were 11 % higher with the Step II diet than with the AAD . The high-MUFA diets did not lower HDL cholesterol whereas the Step II diet lowered it by 4 % compared with the AAD . The OO , PO , and PPB diets decreased CVD risk by an estimated 25 % , 16 % , and 21 % , respectively , whereas the Step II diet lowered CVD risk by 12 % . CONCLUSION A high-MUFA , cholesterol-lowering diet may be preferable to a low-fat diet because of more favorable effects on the CVD risk profile BACKGROUND Metabolic studies suggest that saturated fatty acids differ in their effects on blood lipids . OBJECTIVE The objective was to examine the associations between intakes of individual saturated fatty acids and their food sources in relation to the risk of coronary heart disease ( CHD ) .  DESIGN This was a prospect i ve cohort study of 80082 women in the Nurses ' Health Study aged 34 - 59 y. Subjects had no known cardiovascular disease , cancer , hypercholesterolemia , or diabetes , and completed vali date d food-frequency question naires in 1980 . RESULTS During 14 y of follow-up , we documented 939 incident cases of major CHD events . In multivariate analyses in which age , smoking , and other covariates were controlled for , intakes of short- to medium-chain saturated fatty acids ( 4:0 - 10:0 ) were not significantly associated with the risk of CHD . In contrast , intakes of longer-chain saturated fatty acids ( 12:0 - 18:0 ) were each separately associated with a small increase in risk . The multivariate RR for a 1 % energy increase from stearic acid was 1.19 ( 95 % CI : 1.02 , 1.37 ) . The ratio of polyunsaturated to saturated fat was strongly and inversely associated with CHD risk ( multivariate RR for a comparison of the highest with the lowest deciles : 0.58 ; 95 % CI : 0.41 , 0.83 ; P for trend < 0.0001 ) . Conversely , higher ratios of red meat to poultry and fish consumption and of high-fat to low-fat dairy consumption were associated with significantly greater risk . CONCLUSION A distinction between stearic acid and other saturated fats does not appear to be important in dietary advice to reduce CHD risk , in part because of the high correlation between stearic acid and other saturated fatty acids in typical diets Objective : To investigate the consumption of industrial trans-fatty acids ( TFAs )  in Iranian homes and the proportion of coronary heart disease ( CHD ) events in Iran attributable to such intake . Design , setting and participants : The consumption of industrial TFAs was determined using ( 1 ) detailed in-home assessment s of dietary intake among 7158 urban and rural households containing 35 924 individuals and ( 2 ) gas chromatography to determine TFA contents of the most commonly consumed partially hydrogenated oils . The population -attributable risk for CHD owing to TFA consumption was calculated on the basis of ( 1 ) documented effects of TFAs on total : high-density lipoprotein ( HDL ) cholesterol in r and omized controlled dietary trials and ( 2 ) relationships of TFA intake with incidence of CHD in prospect i ve observational studies . Results : Partially hydrogenated oils were used extensively for cooking in Iranian homes with average per-person intake of 14 g/1000 kcal .  TFAs  accounted for 33 % of fatty acids in these products , or 4.2 % of all calories consumed ( 12.3 g/day ) . On the basis of total : HDL cholesterol effects alone , 9 % of CHD events would be prevented by replacement of TFA in Iranian homes with cis-unsaturated fats ( 8 % by replacement with saturated fats ) . On the basis of relationships of TFA intake with CHD incidence in prospect i ve studies , 39 % of CHD events would be prevented by replacement of TFA with cis-unsaturated fats ( 31 % by replacement with saturated fats ) . These population -attributable risks may be overestimates owing to competing risks and because not all the fat used for cooking might actually be consumed . If actual TFA consumption were only half as large , the estimated proportion of CHD events prevented by TFA elimination would be 5 % on the basis of total : HDL cholesterol effects and replacement with cis-unsaturated ( 4 % for replacement with saturated fats ) , and 22 % on the basis of prospect i ve studies and replacement with cis-unsaturated fats ( 17 % for replacement with saturated fats ) . These estimates do not include possible additional benefits derived from replacing TFAs with vegetable oils containing n-3 fatty acids . Conclusions : Intake of TFAs is high in Iranian homes and contributes to a sizeable proportion of CHD events . Replacement of partially hydrogenated oils with unhydrogenated oils would likely produce substantial reductions in CHD incidence . Sponsorship : National Heart , Lung and Blood Institute , National Institutes of Health , USA . National Nutrition & Food Technology Research Institute , Tehran , Iran The results of large prospect i ve epidemiologic investigations support the hypothesis that coronary disease risk depends on the quality rather than quantity of dietary fat . Whereas saturated fat and cholesterol appear to increase the risk of coronary heart disease ( CHD ) as predicted by their effects on blood lipids , strong evidence has emerged that the deleterious effects of trans unsaturated fatty acids ( trans fatty acids ) extend beyond those predicted by their well-known adverse influence on the ratio of low-density lipoprotein to high-density lipoprotein cholesterol . On the other h and , increased consumption of the polyunsaturated fats , linoleic acid and linolenic acid , appears to reduce the risk of CHD Introduction High dietary saturated fat intake is associated with higher blood concentrations of low-density lipoprotein cholesterol ( LDL-C ) , an established risk factor for coronary heart disease . However , there is increasing interest in whether various dietary oils or fats with different fatty acid profiles such as extra virgin coconut oil may have different metabolic effects but trials have reported inconsistent results . We aim ed to compare changes in blood lipid profile , weight , fat distribution and metabolic markers after four weeks consumption of 50 g daily of one of three different dietary fats , extra virgin coconut oil , butter or extra virgin olive oil , in healthy men and women in the general population . Design R and omised clinical trial conducted over June and July 2017 . Setting General community in Cambridgeshire , UK . Participants Volunteer adults were recruited by the British Broadcasting Corporation through their websites . Eligibility criteria were men and women aged 50–75 years , with no known history of cancer , cardiovascular disease or diabetes , not on lipid lowering medication , no contraindications to a high-fat diet and willingness to be r and omised to consume one of the three dietary fats for 4 weeks . Of 160 individuals initially expressing an interest and assessed for eligibility , 96 were r and omised to one of three interventions ; 2 individuals subsequently withdrew and 94 men and women attended a baseline assessment . Their mean age was 60 years , 67 % were women and 98 % were European Caucasian . Of these , 91 men and women attended a follow-up assessment 4 weeks later . Intervention Participants were r and omised to extra virgin coconut oil , extra virgin olive oil or unsalted butter and asked to consume 50 g daily of one of these fats for 4 weeks , which they could incorporate into their usual diet or consume as a supplement . Main outcomes and measures The primary outcome was change in serum LDL-C ; secondary outcomes were change in total and high-density lipoprotein cholesterol ( TC and HDL-C ) , TC/HDL-C ratio and non-HDL-C ; change in weight , body mass index ( BMI ) , waist circumference , per cent body fat , systolic and diastolic blood pressure , fasting plasma glucose and C reactive protein . Results LDL-C concentrations were significantly increased on butter compared with coconut oil ( + 0.42 , 95 % CI 0.19 to 0.65 mmol/L , P<0.0001 ) and with olive oil ( + 0.38 , 95 % CI 0.16 to 0.60 mmol/L , P<0.0001 ) , with no differences in change of LDL-C in coconut oil compared with olive oil ( −0.04 , 95 % CI −0.27 to 0.19 mmol/L , P=0.74 ) . Coconut oil significantly increased HDL-C compared with butter ( + 0.18 , 95 % CI 0.06 to 0.30 mmol/L ) or olive oil ( + 0.16 , 95 % CI 0.03 to 0.28 mmol/L ) . Butter significantly increased TC/HDL-C ratio and non-HDL-C compared with coconut oil but coconut oil did not significantly differ from olive oil  for TC/HDL-C and non-HDL-C. There were no significant differences in changes in weight , BMI , central adiposity , fasting blood glucose , systolic or diastolic blood pressure among any of the three intervention groups . Conclusions and relevance Two different dietary fats ( butter and coconut oil ) which are predominantly saturated fats , appear to have different effects on blood lipids compared with olive oil , a predominantly monounsaturated fat with coconut oil more comparable to olive oil with respect to LDL-C. The effects of different dietary fats on lipid profiles , metabolic markers and health outcomes may vary not just according to the general classification of their main component fatty acids as saturated or unsaturated but possibly according to different profiles in individual fatty acids , processing methods as well as the foods in which they are consumed or dietary patterns . These findings do not alter current dietary recommendations to reduce saturated fat intake in general but highlight the need for further elucidation of the more nuanced relationships between different dietary fats and health . Trial registration number NCT03105947 ; Results OBJECTIVE Palm and palm olein ( PO ) oils are used in some infant formula fat blends to match the fatty acid profile of human milk , but their presence has been shown to lower calcium and fat absorption . We aim ed to determine if the reported differences in calcium absorption could affect skeletal development by comparing bone mineral accretion in healthy term infants fed a milk-based formula with ( PMF ) or without PO . METHODS Whole body bone mineralization was evaluated in healthy term infants fed 1 of 2 coded , commercially available , ready-to-feed infant formulas in a r and omized , double-blind , parallel study . Subjects were fed either 1 ) . PMF formula ( Enfamil with iron ; Mead Johnson Division of Bristol Myers , Evansville , IN ; N = 63 ) containing PO/coconut/soy/high-oleic sunflower oils ( 45/20/20/15 % oil ) ; or 2 ) . milk-based formula without PO ( Similac with iron ; Ross Products Division Abbott Laboratories , Columbus , OH ; N = 65 ) , containing high-oleic safflower/coconut/soy oils ( 40/30/30 % oil ) from enrollment by 2 weeks after birth until 6 months . Anthropometrics and formula intake were determined monthly ; total body bone mineral content ( BMC ) and bone mineral density ( BMD ) were measured at baseline , 3 , and 6 months of age using dual energy x-ray absorptiometry . RESULTS Intent-to-treat analyses indicated no significant differences between feeding groups in weight , length , head circumference , or formula intake throughout the study . BMC and BMD were not different at baseline but repeated measures analyses show that infants fed PMF had significantly lower BMC and BMD at 3 and 6 months . CONCLUSIONS Healthy term infants fed a formula containing PO as the predominant oil in the fat blend had significantly lower BMC and BMD than those fed a formula without PO . The inclusion of PO in infant formula at levels needed to provide a fatty acid profile similar to that of human milk leads to lower bone mineralization BACKGROUND Dietary behenic acid ( 22:0 ) is poorly absorbed . Because of its low bioavailability compared with other fatty acids and because of its very long chain length , the effect of dietary behenic acid ( behenate ) on serum lipid concentrations in humans is assumed to be neutral . OBJECTIVE The objective was to establish the cholesterol-raising potential of behenic acid by comparing the effects on lipid and lipoprotein concentrations of a specially formulated fat enriched with behenic acid with those of palm oil ( rich in palmitic acid ; 16:0 ) and high-oleic acid sunflower oil ( rich in cis oleic acid ; 18:1 ) . DESIGN In a r and omized , crossover , metabolic-ward study , 7 mildly hypercholesterolemic men were fed 3 natural-food diets supplemented with behenate oil , palm oil , or high-oleic acid sunflower oil .  Mean serum lipid and lipoprotein concentrations and plasma triacylglycerol fatty acid composition were determined from fasting blood drawn during the final 4 d of each 3-wk diet period . RESULTS Behenate oil produced mean concentrations of total cholesterol ( 5.87+/-0.8 mmol/L ) and LDL cholesterol ( 4.40+/-0.8 mmol/L ) not significantly different from those produced by palm oil ( 5.84+/-0.7 and 4.42+/-0.7 mmol/L , respectively ) but significantly higher than those produced by high-oleic acid sunflower oil ( 5.12+/-0.5 and 3.70+/-0.6 mmol/L , respectively ) . There were no significant differences in triacylglycerol or HDL-cholesterol concentrations . CONCLUSIONS Despite its low bioavailability compared with oleic acid , behenic acid is a cholesterol-raising fatty acid in humans and is therefore not a suitable substitute for palmitic acid in manufactured triacylglycerols Thirty-eight male volunteers participated in a double-blind cross-over trial evaluating the effect of replacing the usual sources of saturated fat in the Dutch diet ( animal fats and hydrogenated oils ) by palm oil , which is virtually free of cholesterol and trans-fatty acids , on serum lipids , lipoproteins and apolipoproteins . Maximum ( about 70 % ) replacement had no significant effect on serum total cholesterol or most lipoprotein fractions , but result ed in an 11 % increase in serum high-density-lipoprotein (HDL)2-cholesterol relative to the control ( P2 = 0.01 ) . The palm-oil diet also caused an 8 % decrease in low-density-lipoprotein (LDL):HDL2 + HDL3-cholesterol ratio ( P2 = 0.02 ) as well as a 9 % decrease in triacylglycerols in the low-density-lipoprotein fractions ( P2 = 0.01 ) . Palm oil consumption result ed in a 4 % increase in serum apolipoprotein AI ( P2 = 0.008 ) and a 4 % decrease in apolipoprotein B ( P2 = 0.01 ) relative to the control diet ; the B : AI apolipoprotein ratio was decreased by 8 % ( P2 < 0.0001 ) . These results were not significantly affected by the different lipoprotein E phenotypes of the volunteers . Although the observed differences were relatively modest , the present study , nonetheless , indicates that dietary palm oil , when replacing a major part of the normal fat content in a Dutch diet , may slightly reduce the lipoprotein- and apolipoprotein-associated cardiovascular risk profiles BACKGROUND Public health strategies to lower cardiovascular disease ( CVD ) risk involve reducing dietary saturated fatty acid ( SFA ) intake to ≤10 % of total energy ( % TE ) . However , the optimal type of replacement fat is unclear . OBJECTIVE We investigated the substitution of 9.5 - 9.6%TE dietary SFAs with either monounsaturated fatty acids ( MUFAs ) or n-6 ( ω-6 ) polyunsaturated fatty acids ( PUFAs ) on vascular function and other CVD risk factors . DESIGN In a r and omized , controlled , single-blind , parallel-group dietary intervention , 195 men and women aged 21 - 60 y from the United Kingdom with moderate CVD risk ( ≥50 % above the population mean ) followed one of three 16-wk isoenergetic diets ( % TE target compositions , total fat : SFA : MUFA : n-6 PUFA ) that were rich in SFAs ( 36:17:11:4 , n = 65 ) , MUFAs ( 36:9:19:4 , n = 64 ) , or n-6 PUFAs ( 36:9:13:10 , n = 66 ) . The primary outcome measure was flow-mediated dilatation ; secondary outcome measures included fasting serum lipids , microvascular reactivity , arterial stiffness , ambulatory blood pressure , and markers of insulin resistance , inflammation , and endothelial activation . RESULTS Replacing SFAs with MUFAs or n-6 PUFAs did not affect the percentage of flow-mediated dilatation ( primary endpoint ) or other measures of vascular reactivity . Of the secondary outcome measures , substitution of SFAs with MUFAs attenuated the increase in night systolic blood pressure ( -4.9 mm Hg , P = 0.019 ) and reduced E-selectin ( -7.8 % , P = 0.012 ) . Replacement with MUFAs or n-6 PUFAs lowered fasting serum total cholesterol ( -8.4 % and -9.2 % , respectively ) , low-density lipoprotein cholesterol ( -11.3 % and -13.6 % ) , and total cholesterol to high-density lipoprotein cholesterol ratio ( -5.6 % and -8.5 % ) ( P ≤ 0.001 ) . These changes in low-density lipoprotein cholesterol equate to an estimated 17 - 20 % reduction in CVD mortality . CONCLUSIONS Substitution of 9.5 - 9.6%TE dietary SFAs with either MUFAs or n-6 PUFAs did not significantly affect the percentage of flow-mediated dilatation or other measures of vascular function . However , the beneficial effects on serum lipid biomarkers , blood pressure , and E-selectin offer a potential public health strategy for CVD risk reduction . This trial was registered at www . clinical trials.gov as NCT01478958 The effect on the fasting serum lipid levels of adding daily 291 mg of cholesterol to diets containing 3 mg of cholesterol and equal fat content , but different fatty acid composition , was tested on 12 young men . The saturated diet provided 97 g/day of a staurated oil made up of 2 parts of palm oil and 1 part of coconut oil . The polyunsatured diet provided 97 g/day of safflower oil . The cholesterol was dissolved in 40 g of either oil incorporated into a spread . A similar spread , devoid of cholesterol , was fed during the cholesterol free periods . Duration of dietary periods was 14 days . Addition of cholesterol produced a mean elevation of serum cholesterol of 9 mg/dl ( SE + /- 2.1 ) in the presence of the saturated diet , and of 8 mg/dl ( SE + /- 1.6 ) in the presence of the polyunsaturated diet . Both cholesterol elevations were significant ( P less than 0.01 ) but not significantly different from each other . Substitution of the saturated diet for the polyunsatured diet caused a significant elevation of serum cholesterol which was the same when the substitution was made in the presence or in the absence of added dietary cholesterol The effect of fats high in individual , prevalent saturated dietary fatty acids on lipoproteins and hemostatic variables in young healthy subjects was evaluated in a r and omized strictly controlled metabolic feeding study . Three experimental diets : shea butter ( S ; 42 % stearic acid ) , palm oil ( P ; 43 % palmitic palmitic acid ) , and palm-kernel oil with high-oleic sunflower oil ( ML ; 10 % myristic acid , 30 % lauric acid ) were served to 15 men for 3 wk each , separated by washout periods . Diet S compared with diet P result ed in significant reduction in plasma cholesterol ( 22 % ) LDL cholesterol ( 26 % ) , apolipoprotein B ( 18 % ) , HDL cholesterol ( 12 % ) , apolipoprotein A-I ( 13 % ) , and a 13 % lower factor VII coagulant activity ( P = 0.001 ) . Similar differences were observed between diets S and ML . In conclusion , intake of shea butter high in stearic acid favorably affects blood lipids and factor VII coagulant activity in young men , compared with fats high in saturated fatty acids with 12 - 16 carbons BACKGROUND Nutritional therapy is a cornerstone of diabetes management , but no epidemiologic studies have investigated the relation between specific dietary fatty acids and cholesterol and cardiovascular disease ( CVD ) risk  among diabetic patients . OBJECTIVE This study assessed the relation between specific dietary fatty acids and cholesterol and CVD risk among women with type 2 diabetes . DESIGN Among 5672 women with type 2 diabetes from the Nurses ' Health Study , diet was assessed prospect ively and up date d periodically .  Relative risks of CVD were estimated from Cox proportional hazards analysis after adjustment for potential confounders . RESULTS Between 1980 and 1998 , we identified 619 new cases of CVD ( nonfatal myocardial infa rct ion , fatal coronary heart disease , and stroke ) . The relative risk ( RR ) of CVD for an increase of 200 mg cholesterol/1000 kcal was 1.37 ( 95 % CI : 1.12 , 1.68 ; P = 0.003 ) . Each 5 % of energy intake from saturated fat , as compared with equivalent energy from carbohydrates , was associated with a 29 % greater risk of CVD ( RR : 1.29 ; 95 % CI : 1.02 , 1.63 ; P = 0.04 ) . The ratio of polyunsaturated to saturated fat ( P : S ) was inversely associated with the risk of fatal CVD . We estimated that replacement of 5 % of energy from saturated fat with equivalent energy from carbohydrates or monounsaturated fat was associated with a 22 % or 37 % lower risk of CVD , respectively . CONCLUSIONS A higher intake of cholesterol and saturated fat and a low P : S were related to increased CVD risk among women with type 2 diabetes . Among diabetic persons , replacement of saturated fat with monounsaturated fat may be more effective in lowering CVD risk than is replacement with carbohydrates BACKGROUND The quantity and quality of fats consumed in the diet influence the risk of cardiovascular disease ( CVD ) . Although the effect of diet on plasma lipids and lipoproteins is well documented , less information exists on the role of fats on blood pressure ( BP ) . OBJECTIVE The objective was to evaluate the effects of different types of dietary fat on BP in healthy subjects . DESIGN Healthy subjects ( n = 162 ) were r and omly assigned for 3 mo to follow 1 of 2 isoenergetic diets : 1 rich in monounsaturated fatty acids ( MUFA diet ) and the other rich in saturated fatty acids ( SFA diet ) . Each group was further r and omly assigned to receive supplementation with fish oil ( 3.6 g n-3 fatty acids/d ) or placebo . RESULTS Systolic BP ( SBP ) and diastolic BP ( DBP ) decreased with the MUFA diet [ -2.2 % ( P = 0.009 ) and -3.8 % ( P = 0.0001 ) , respectively ] but did not change with the SFA diet [ -1.0 % ( P = 0.2084 ) and -1.1 % ( P = 0.2116 ) ] . The MUFA diet caused a significantly lower DBP than did the SFA diet ( P = 0.0475 ) . Interestingly , the favorable effects of MUFA on DBP disappeared at a total fat intake above the median ( > 37 % of energy ) . The addition of n-3 fatty acids influenced neither SBP nor DBP . CONCLUSIONS Changing the proportions of dietary fat by decreasing SFAs and increasing MUFAs decreased diastolic BP . Interestingly , the beneficial effect on BP induced by fat quality was negated by the consumption of a high total fat intake . The addition of n-3 fatty acids to the diet had no significant effect on BP Background : Studies of long-term intake of industrially produced trans fatty acids ( TFA ) and n-3 polyunsaturated fatty acids ( PUFA ) suggest opposite effects on cardiovascular disease risk . Common mechanisms of action are probable . Objective : To examine the effects on cardiovascular risk markers of dietary enrichment with TFA or n-3 PUFA . Design : R and omized , double-blind , parallel intervention trial . Setting : Department of Human Nutrition , The Royal Veterinary and Agricultural University . Subjects : In all , 87 healthy males included , 79 completed . Intervention : Subjects were r and omly assigned to 8 weeks of a daily intake of 33 g of experimental fats from either partially hydrogenated soy oil containing 20 g of TFA , 12 g of fish oil with approximately 4 g of n-3 PUFA and 21 g of control fat , or 33 g of control fat . The experimental fats were incorporated into bakery products .  Plasma lipids , blood pressure , heart rate variability ( HRV ) , arterial dilatory capacity , compliance , and distensibility were recorded before and after intervention and at follow-up 12 weeks after the intervention . Results : High-density lipoprotein cholesterol ( HDL-C ) decreased in the TFA group and triglycerides and mean arterial blood pressure decreased in the n-3 PUFA group compared to the control group . HRV , arterial dilatory capacity , compliance , and distensibility were unchanged . Conclusion : The results indicate that the association between coronary heart disease risk and intake of TFA and n-3 PUFA relates only modestly to changes in traditional risk markers . Sponsorship : Danish Medical Research Council ( Grant no. 22 - 01 - 0390 ) , Center of Advanced Food Research ( Copenhagen , Denmark ) ( Grant no. KVL-R-2001 - 107 ) , the Danish Heart Association ( Grant no. 99 - 2 - 3 - 45 - 22748 ) , Novozymes ( Bagsvaerd , Denmark ) , Aarhus Olie ( Aarhus , Denmark ) , and from private sources . The experimental fats were provided by Pronova Biocare ( Aalesund , Norway ) and Aarhus Olie ( Aarhus , Denmark ) Background and rationale Coronary artery disease ( CAD ) and its pathological atherosclerotic process are closely related to lipids . Lipids levels are in turn influenced by dietary oils and fats . Saturated fatty acids increase the risk for atherosclerosis by increasing the cholesterol level . This study was conducted to investigate the impact of cooking oil media ( coconut oil and sunflower oil ) on lipid profile , antioxidant mechanism , and endothelial function in patients with established CAD . Design and methods In a single center r and omized study in India , patients with stable CAD on st and ard medical care were assigned to receive coconut oil ( Group I ) or sunflower oil ( Group II ) as cooking media for 2 years . Anthropometric measurements , serum , lipids , Lipoprotein a , apo B/A-1 ratio , antioxidants , flow-mediated vasodilation , and cardiovascular events were assessed at 3 months , 6 months , 1 year , and 2 years . Results Hundred patients in each arm completed 2 years with 98 % follow-up . There was no statistically significant difference in the anthropometric , biochemical , vascular function , and in cardiovascular events after 2 years . Conclusion Coconut oil even though rich in saturated fatty acids in comparison to sunflower oil when used as cooking oil media over a period of 2 years did not change the lipid-related cardiovascular risk factors and events in those receiving st and ard medical care BACKGROUND Substitution of dietary polyunsaturated for saturated fat has long been recommended for the primary prevention of cardiovascular disease ( CVD ) , but only a few prospect i ve cohort studies have provided support for this advice . METHODS We assessed the association of dietary linoleic and total polyunsaturated fatty acid ( PUFA ) intake with cardiovascular and overall mortality in a population -based cohort of 1551 middle-aged men . Dietary fat composition was estimated with a 4-day food record and serum fatty acid composition . RESULTS During the 15-year follow-up , 78 men died of CVD and 225 of any cause . Total fat intake was not related to CVD or overall mortality . Men with an energy-adjusted dietary intake of linoleic acid ( relative risk [ RR ] 0.39 ; 95 % confidence interval [ CI ] , 0.21 - 0.71 ) and PUFA ( RR , 0.38 ; 95 % CI , 0.20 - 0.70 ) in the upper third were less likely to die of CVD than men with intake in the lower third after adjustment for age . Multivariate adjustment weakened the association somewhat . Mortality from CVD was also lower for men with proportions of serum esterified linoleic acid ( RR , 0.42 ; 95 % CI , 0.21 - 0.80 ) and PUFA ( RR , 0.25 ; 95 % CI , 0.12 - 0.50 ) in the upper vs lower third , with some attenuation in multivariate analyses . Serum and to a lesser extent dietary linoleic acid and PUFA were also inversely associated with overall mortality . CONCLUSIONS Dietary polyunsaturated and more specifically linoleic fatty acid intake may have a substantial cardioprotective benefit that is also reflected in overall mortality . Dietary fat quality seems more important than fat quantity in the reduction of cardiovascular mortality in men Background Evidence regarding the role of dairy fat intake in  cardiovascular disease (  CVD ) has been mixed and inconclusive . Most earlier studies have used self‐reported measures of dietary intake and focused on relatively racially homogeneous population s. Circulating biomarkers of dairy fat in a multiethnic cohort provide objective measures of dairy fat intake and facilitate conclusions relevant to population s with different diets and susceptibility to CVD . Methods and Results In a multiethnic cohort of 2837 US adults aged 45 to 84 years at baseline ( 2000–2002 ) , phospholipid fatty acids including 15:0 , 14:0 , and trans‐16:1n7 were measured using st and ardized methods , and the incidence of CVD prospect ively adjudicated . Self‐reported whole‐fat dairy and butter intakes had strongest associations with 15:0 , rather than 14:0 or trans‐16:1n7 . In multivariate models including demographics and lifestyle and dietary habits , each SD‐unit of 15:0 was associated with 19 % lower CVD risk ( hazard ratio [ 95 % CI ] 0.81 [ 0.68 to 0.98 ] ) and 26 % lower coronary heart disease ( CHD ) risk ( 0.74 [ 0.60 to 0.92 ] ) . Associations were strengthened after mutual adjustment for 14:0 and trans‐16:1n‐7 and were similar after adjustment for potential mediators . Plasma phospholipid 14:0 and trans‐16:1n‐7 were not significantly associated with incident CVD or CHD . All findings were similar in white , black , Hispanic , and Chinese American participants .  Conclusion Plasma phospholipid 15:0 , a biomarker of dairy fat , was inversely associated with incident CVD and CHD , while no association was found with phospholipid 14:0 and trans‐16:1n‐7 . These findings support the need for further investigation of CVD effects of dairy fat , dairy‐specific fatty acids , and dairy products in general BACKGROUND The issue of whether saturated fats and trans fats are superior predictors of all-cause death and cardiovascular disease than n-3 polyunsaturated fatty acids , such as eicosapentaenoic acid ( EPA ) and docosahexaenoic acid ( DHA ) , remains a matter of contention . Furthermore , few studies have examined the relationship between fatty acids and the outcomes of cardiovascular disease ( CVD ) in Asian population s. The aim of this study was to compare the effectiveness of various plasma fatty acids as predictors for all-cause death and CVD events in an ethnic Chinese population . METHODS This study assembled a community-based prospect i ve cohort , comprising 1833 participants ( 60.6 ± 10.5 yrs , 44.5 % women ) who underwent a comprehensive evaluation of fatty acids in blood using gas chromatography . None of the subjects had a history of CVD at the time of recruitment . RESULTS A total of 568 individuals died and 275 individuals developed CVD during the follow-up period ( median of 9.6 years ; interquartile range of 8.9 - 10.5 years ) . Following adjustment for established cardiovascular risk factors , the relative risk of all-cause death in the highest quartile , compared with the lowest quartile , was 1.33 for saturated fats ( 95 % confidence interval [ CI ] , 1.01 - 1.75 , test for trend , P = 0.015 ) , 1.71 for trans fats ( 95 % CI , 1.27 - 2.31 , test for trend , P = 0.0003 ) , 0.77 for EPA ( 95 % CI , 0.59 - 1.00 , test for trend , P = 0.048 ) , and 0.89 for DHA ( 95 % CI , 0.68 - 1.18 , test for trend , P = 0.354 ) . Similar patterns were observed for CVD events  . Trans fats presented the largest area under the receiver operator characteristic curve ( 0.740 , 95 % CI , 0.716 - 0.766 ) for the prediction of all-cause death . A mutually adjusted two-marker model indicated that saturated fats and trans fats were significant predictors of all-cause death and CVD ; however , the other fatty acids were not . In addition , trans fats presented the greatest improvement in net reclassification for all-cause death ( 7.7 % , P = 0.003 ) , followed by EPA ( 3.8 % , P = 0.033 ) . Saturated fats presented the greatest improvement in net reclassification for CVD events ( 5.6 % , P = 0.039 ) . CONCLUSIONS Our data provides strong evidence to support that plasma saturated fats and trans fats can predict all-cause death and CVD more effectively than other fatty acid markers We have compared the effects of three different margarines , one based on palm oil ( PALM-margarine ) , one based on partially hydrogenated soybean oil ( TRANS-margarine ) and one with a high content of polyunsaturated fatty acids ( PUFA-margarine ) , on serum lipids in 27 young women . The main purpose of the study was to test if replacement of trans fatty acids in margarine by palmitic acid results in unfavorable effects on serum lipids . The sum of saturated fatty acids ( 12∶0 , 14∶0 , 16∶0 ) was 36.3 % of total fatty acids in the PALM-diet , the same as the sum of saturated ( 12∶0 , 14∶0 , 16∶0 ) ( 12.5 % ) and trans ( 23.1 % ) fatty acids in the TRANS-diet . This sum was 20.7 % in the PUFA-diet . The content of oleic acid was 37.9 , 35.2 , and 38.6 % , respectively , in the three diets , whereas linoleic acid amounted to 16 , 13.5 , and 27.3 % , respectively . Total fat provided 30–31 % and the test margarines 26 % of total energy in all three diets . The subjects consumed each of the diets for 17 d in a Latin-square crossover design . There were no significant differences in total cholesterol , low density lipoprotein (LDL)-cholesterol and apolipoprotein B ( apoB ) between the TRANS- and the PALM-diets . High density lipoprotein (HDL)-cholesterol and apoA-I were significantly higher on the PALM-diet compared to the TRANS-diet whereas the ratio of LDL-cholesterol to HDL-cholesterol was lower , although not significantly ( P=0.077 ) on the PALM-diet . Total cholesterol , LDL-cholesterol , and apoB were significantly lower on the PUFA-diet compared to the two other diets . HDL-cholesterol was not different on the PALM- and the PUFA-diets but it was significantly lower on the TRANS-diet compared to the PUFA diet . Compared to the PUFA-diet  the ratio of LDL-to HDL-cholesterol was higher on both the PALM- and the TRANS-diets whereas apoA-I was not different . Triglycerides and lipoprotein ( a ) were not significantly different among the three diets . We concluded that nutritionally , palmitic acid from palm oil may be a reasonable alternative to trans fatty acids from partially hydrogenated soybean oil in margarine if the aim is to avoid trans fatty acids . A palm oil-based margarine is , however , less favorable than one based on a more polyunsaturated vegetable oil Background / objectives : Dietary triacylglycerols containing palmitic acid in the sn-2 position might impair insulin release and increase plasma glucose . Subjects/ Methods : We used a cross-over design ed feeding trial in 53 healthy Asian men and women ( 20–50 years ) to test this hypothesis by exchanging 20 % energy of palm olein ( PO ; control ) with r and omly interesterified PO ( IPO ) or high oleic acid sunflower oil ( HOS ) . After a 2-week run-in period on PO , participants were fed PO , IPO and HOS for 6 week consecutively in r and omly allocated sequences . Fasting ( midpoint and endpoint ) and postpr and ial blood at the endpoint following a test meal ( 3.54 MJ , 14 g protein , 85 g carbohydrate and 50 g fat as PO ) were collected for the measurement of C-peptide , insulin , glucose , plasma glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 , lipids and apolipoproteins ; pre-specified primary and secondary outcomes were postpr and ial changes in C-peptide and plasma glucose . Results : Low density lipoprotein cholesterol was 0.3 mmol/l ( 95 % confidence interval ( 95 % CI ) ) 0.1 , 0.5 ; P<0.001 ) lower on HOS than on PO or IPO as predicted , indicating good compliance to the dietary intervention . There were no significant differences ( P=0.58 ) between diets among the 10 male and 31 female completers in the incremental area under the curve ( 0–2 h ) for C-peptide in nmol.120 min/l : GM ( 95 % CI ) were PO 220 ( 196 , 245 ) , IPO 212 ( 190 , 235 ) and HOS 224 ( 204 , 244 ) . Plasma glucose was 8 % lower at 2 h on IPO vs PO and HOS ( both P<0.05 ) . Conclusion : Palmitic acid in the sn-2 position does not adversely impair insulin secretion and glucose homeostasis BACKGROUND AND OBJECTIVES As the most widely produced edible vegetable oil , palm oil is known as to contain a high level of saturated fatty acid , which was thought to adversely affect serum lipid profiles . However , recent studies have shown no influence or benefits of palm oil on serum lipids . The potential nutritional value of palm oil is attributed to the high mono-unsaturation at the crucial sn2-position of the oil 's triacylglycerols , as with the so-called ' healthy ' olive oil ( OO ) . The aim of this study was to further test this hypothesis and evaluate the effects of consuming palm olein versus olive oil on serum lipid profiles in a Chinese population . METHODS AND STUDY DESIGN In total , 120 participants were recruited from a spinnery in Yixing city and r and omly divided into two groups ( palm olein or olive oil ) to conduct a 2 × 2 crossover trial for 2 months ' intervention with 2-week washout periods . Each participant was provided 48 g of test oil per day . At the end of each period , anthropometry , and blood lipid indices were measured to determine the effects of palm olein and olive oil . RESULTS Palm olein and olive oil consumption had no significantly different effect on BMI , on serum total cholesterol , low-density lipoprotein cholesterol , high-density lipoprotein cholesterol , triacylglycerol ( TG ) , Apo B , fasting glucose , or insulin concentrations ( all p>0.05 ) . CONCLUSIONS In a dietary crossover trial , palm olein and olive oil had no recognisably different effects on body fatness or blood lipids in a healthy Chinese population
Comparison of PO diets with diets rich in stearic acid , monounsaturated fatty acids ( MUFAs ) , and polyunsaturated fatty acids ( PUFAs ) showed significantly higher TC , LDL cholesterol , apolipoprotein B , HDL cholesterol , and apolipoprotein A-I , whereas most of the same biomarkers were significantly lower when compared with diets rich in myristic/lauric acid .
Comparison of PO-rich diets with diets rich in trans fatty acids showed significantly higher concentrations of HDL cholesterol and apolipoprotein A-I and significantly lower apolipoprotein B , triacylglycerols , and TC/HDL cholesterol .
Stratified and meta-regression analyses showed that the higher concentrations of TC and LDL cholesterol , when PO was substituted for MUFAs and PUFAs , were not significant in young people and in subjects with diets with a lower percentage of energy from fat .
Both favorable and unfavorable changes in CHD/CVD risk markers occurred when PO was substituted for the primary dietary fats , whereas only favorable changes occurred when PO was substituted for trans fatty acids .
BACKGROUND Palm oil ( PO ) may be an unhealthy fat because of its high saturated fatty acid content .
OBJECTIVE The objective was to assess the effect of substituting PO for other primary dietary fats on blood lipid-related markers of coronary heart disease ( CHD ) and cardiovascular disease ( CVD ) .